A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay +44 more·2018·Cell
DOI 10.1016/j.cell.2018.09.006

Cited by (999)

Items 501–600 of 999

  1. Beyond cell cycle regulation: The pleiotropic function of CDK4 in cancer
    Dorian V. Ziegler, Kanishka Parashar, Lluis Fajas A · 2023 · Seminars in Cancer Biology
  2. A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells
    Yu Wei Zhang, Ana Gvozdenovic, Nicola Aceto · 2024 · Cancer Discovery
  3. CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma
    Xiyue Xu, Yidan Zhang, Yaxiao Lu, Xiaoyan Zhang, Cuicui Zhao, Jiesong Wang, Qingpei Guan, Yingfang Feng, Meng Gao, Jingwei Yu et al. · 2024 · Cancer Research
  4. Clinical and translational implications of immunotherapy in sarcomas
    Federica Recine, Silvia Vanni, Alberto Bongiovanni, Valentina Fausti, Laura Mercatali, Giacomo Miserocchi, Chiara Liverani, Federica Pieri, Roberto Casadei, Davide Cavaliere et al. · 2024 · Frontiers in Immunology
  5. Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
    Jiawei Song, Jun Wei Zhu, Yu Jiang, Yajie Guo, Shuai Liu, Yihuan Qiao, Yongtao Du, Jipeng Li · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  6. Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
    Yosuke Ishitsuka, Yuma Hanaoka, Atsushi Tanemura, Manabu Fujimoto · 2021 · Cancers
  7. Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
    Mona Yazdani, Zahra Gholizadeh, Amin Reza Nikpoor, Nema Mohamadian Roshan, Mahmoud Reza Jaafari, Ali Badiee · 2021 · Scientific Reports
  8. Epigenetics of Dendritic Cells in Tumor Immunology
    Gerard Godoy‐Tena, Esteban Ballestar · 2022 · Cancers
  9. Single‐cell transcriptome sequencing reveals SPP1 ‐ CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
    Fuzhong Liu, Junfeng Zhang, Xiaowei Gu, Qiuyang Guo, Wenjia Guo · 2024 · Journal of Cellular and Molecular Medicine
  10. Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy
    Jun‐Long Liang, Xiao‐Kang Jin, Xin‐Chen Deng, Qian‐Xiao Huang, Shi‐Man Zhang, Wei‐Hai Chen, Xian‐Zheng Zhang · 2024 · Materials Today
  11. Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
    Dea Filippini, Sabrina L. D’Agosto, Pietro Delfino, Michele Simbolo, Geny Piro, Borislav Chavdarov Rusev, Lisa Veghini, Cinzia Cantù, Francesca Lupo, Stefano Ugel et al. · 2019 · Scientific Reports
  12. High-Plex Spatial RNA Profiling Reveals Cell Type‒Specific Biomarker Expression during Melanoma Development
    Maija H. Kiuru, Michelle Kriner, Samantha L. Wong, Guannan Zhu, Jessica R. Terrell, Qian Li, Margaret L. Hoang, Joseph Beechem, John D. McPherson · 2021 · Journal of Investigative Dermatology
  13. NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets
    Alice Indini, Irene Fiorilla, Luca Ponzone, Enzo Calautti, Valentina Audrito · 2022 · International Journal of Molecular Sciences
  14. Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
    Xiurong Cai, Adrien Guillot, Hanyang Liu · 2022 · Cells
  15. A transcriptome-based human universal senescence index (hUSI) robustly predicts cellular senescence under various conditions
    Wang, Jing, Zhou, Xiaolan, Yu, Peng, Yao, Jun, Guo, Pengfei, Xu, Qiushi, Zhao, Yuqi, Wang, Guanlong, Li, Qianru, Zhu, Xiaofeng et al. · 2025 · Nature Aging
  16. Entangled cellular and molecular relationships at the sensory neuron-cancer interface
    Debpali Sur, Yi Zeng, Hiroki Hill Kobayashi, Xiaofei Zhi, Mara R. Goetz, Ch. Müller, Anastasia‐Maria Zavitsanou, Caroline C. Picoli, Andre A Martel Matos, Javier R. Pareja et al. · 2025 · Neuron
  17. Dissecting the Tumor–Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach
    Gregory M. Chen, Andrew Azzam, Yangyang Ding, David Maxwell Barrett, Stephan A. Grupp, Kai Tan · 2020 · Clinical Cancer Research
  18. Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
    Arianna Draghi, Christopher Aled Chamberlain, Shawez Khan, Krisztián Papp, Martin Lauss, Samuele Soraggi, Haja Dominike Radic, Mario Presti, Katja Harbst, Aishwarya Gokuldass et al. · 2021 · Frontiers in Immunology
  19. scINSIGHT for interpreting single-cell gene expression from biologically heterogeneous data
    Kun Qian, Shiwei Fu, Hongwei Li, Wei Vivian Li · 2022 · Genome biology
  20. High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade
    Juan Luis Onieva, Qingyang Xiao, Miguel‐Ángel Berciano‐Guerrero, Aurora Laborda-Illanes, Carlos de Andrea, Patricia Cháves, Pilar Piñeiro, Alicia Garrido-Aranda, Elena Gallego, Belén Sojo et al. · 2022 · International Journal of Molecular Sciences
  21. Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma
    Jeongsoo Kim, Tae‐Jin Kim, Sehyun Chae, Hyojeong Ha, Yejin Park, Sung Hee Park, Chul Joo Yoon, Seon Ah Lim, Hyemin Lee, Jiyoung Kim et al. · 2024 · Molecular Cancer
  22. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions
    Simon Durand, Yaqi Tang, Roxane M. Pommier, Valentin Benboubker, Maxime Grimont, Félix Boivin, Laetitia Barbollat‐Boutrand, Eric Cumunel, Florian Dupeuble, Anaïs Eberhardt et al. · 2024 · Oncogene
  23. Boronophenylalanine‐Containing Polydopamine Nanoparticles for Enhanced Combined Boron Neutron Capture Therapy and Photothermal Therapy for Melanoma Treatment
    Liqun Dai, Tao Wang, Siming Zhou, Lili Pan, Yi Lu, Tingyu Yang, Wentao Wang, Zhiyong Qian · 2024 · Advanced Functional Materials
  24. Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment
    Tomoyuki Minowa, Kenji Murata, Yuka Mizue, Aiko Murai, Munehide Nakatsugawa, Kenta Sasaki, Serina Tokita, Terufumi Kubo, Takayuki Kanaseki, Tomohide Tsukahara et al. · 2024 · Science Translational Medicine
  25. Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
    Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell, Elena Kurudza, Piyush Chaudhary, R.L. Belote, Gianpietro Dotti, Robert L. Judson‐Torres, Melissa Quino Reeves, Samuel Henry Cheshier et al. · 2025 · Oncogene
  26. Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma
    Jiekun Yang, Cassia Wang, Doris Fu, Li‐Lun Ho, Kyriaki Galani, Lee Chen, Jose Gonzalez, Jolene Yin Ling Fu, Amy Y. Huang, Dennie Tompers Frederick et al. · 2025 · Nature Communications
  27. Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy
    Sung Hee Lim, Takeshi Kuwata, Minae An, Jung Yong Hong, Seung Tae Kim, Yuki Matsubara, Kohei Shitara, Jeeyun Lee · 2025 · Journal for ImmunoTherapy of Cancer
  28. High-Throughput Multiplex Immunohistochemical Imaging of the Tumor and Its Microenvironment
    Jiwon Koh, Yoonjin Kwak, Jin Kim, Woo Ho Kim · 2019 · Cancer Research and Treatment
  29. Unravelling the heterogeneity and dynamic relationships of tumor-infiltrating T cells by single-cell RNA sequencing analysis
    Xin Yu, Lei Zhang, Ashutosh Chaudhry, Aaron S. Rapaport, Wenjun Ouyang · 2020 · Journal of Leukocyte Biology
  30. Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective
    Nafiseh Erfanian, Afshin Derakhshani, Saeed Nasseri, Mohammad Fereidouni, Behzad Baradaran, Neda Jalili Tabrizi, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Hossein Safarpour · 2021 · Biomedicine & Pharmacotherapy
  31. The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy
    Jing Yi Lee, Bavani Kannan, Boon Yee Lim, Zhimei Li, Abner Herbert Lim, Jui Wan Loh, Tun Kiat Ko, Cedric Chuan Young Ng, Jason Yongsheng Chan · 2022 · International Journal of Molecular Sciences
  32. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
    Boyu Sun, Ziyu Xun, Nan Zhang, Kai Liu, Xiangqi Chen, Haitao Zhao · 2023 · Cancer Cell International
  33. Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment
    Jiehui Deng, Aatish Thennavan, Suhagi M. Shah, Ece Bagdatlioglu, Natalie J. Klar, Adriana Heguy, Christian Marier, Peter Meyn, Yutong Zhang, Kristen E. Labbe et al. · 2020 · Breast Cancer Research and Treatment
  34. Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets
    Qi Wan, Chengxiu Liu, Chang Xin Liu, Weiqin Liu, Xiaoran Wang, Zhichong Wang · 2020 · Frontiers in Oncology
  35. Addressing Resistance to Immune Checkpoint Inhibitor Therapy: An Urgent Unmet Need
    Siwen Hu‐Lieskovan, Gabriel G. Malouf, Ira Allen Jacobs, Jeffrey Chou, Li Liu, Melissa Lynne Johnson · 2021 · Future Oncology
  36. Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research
    Jian Liu, Tianmin Xu, Yuemei Jin, Bingyu Huang, Yan Zhang · 2021 · Frontiers in Oncology
  37. Tumor Microenvironment–Derived R-spondins Enhance Antitumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy
    Yuting Tang, Qian Xu, Liang Hu, Xiaomei Yan, Xiaomin Feng, Asumi Yokota, Weinan Wang, Di Zhan, Durga Krishnamurthy, David E. Ochayon et al. · 2021 · Cancer Discovery
  38. Artificial Assembled Macrophage Co-Deliver Black Phosphorus Quantum Dot and CDK4/6 Inhibitor for Colorectal Cancer Triple-Therapy
    Yuxiao Fang, Zipeng Zhang, Yang Liu, Tong Gao, Shuang Liang, Qihui Chu, Li Guan, Weiwei Mu, Shunli Fu, Huizhen Yang et al. · 2022 · ACS Applied Materials & Interfaces
  39. CDK4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockade in Preclinical Models of Brain Metastasis
    Naema Nayyar, Magali A. de Sauvage, Jane Chuprin, Emily M. Sullivan, Mohini Singh, Consuelo Torrini, Britney S. Zhang, Sushobhana Bandyopadhyay, Keith A. Daniels, Christopher A Alvarez-Breckenridge et al. · 2023 · Clinical Cancer Research
  40. Immune-enhanced and tumor-targeted PDT cascade therapy for oral squamous cell carcinoma utilizing a carrier-free BRD4 inhibitor/PDT agent nanocomplex
    Jiechen Liu, Guangrui Liu, Chunlei Dai, Jun Wu, Qing Li · 2024 · Chemical Engineering Journal
  41. Systematic, Protein Activity-based Characterization of Single Cell State
    Lukas J. Vlahos, A. Obradovic, Jeremy Worley, Xiang-Tian Tan, Andrew Howe, P. Laise, Alexander L. E. Wang, C. G. Drake, A. Califano · 2021 · bioRxiv
  42. Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironment
    Alex C. Soupir, Mitchell T. Hayes, Taylor C. Peak, Oscar E. Ospina, Nicholas Haig Chakiryan, Anders Berglund, Paul A. Stewart, Jonathan V. Nguyen, Carlos Moran Segura, Natasha L. Francis et al. · 2024 · Genome biology
  43. Extracellular vesicle-mediated crosstalk between melanoma and the immune system: Impact on tumor progression and therapy response
    Marco Antônio M. Pretti, Sara Santos Bernardes, Jéssica Gonçalves Vieira da Cruz, Mariana Boroni, Patrícia A. Possik · 2020 · Journal of Leukocyte Biology
  44. CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
    Jingrun Yang, Yang Xu, Kuixia Xie, Ling Gao, Wenying Zhong, Xinhua Liu · 2022 · Frontiers in Immunology
  45. Single-cell dissection of tumor microenvironmental response and resistance to cancer therapy
    Yikai Luo, Han Liang · 2023 · Trends in Genetics
  46. Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods
    Yuxi Cheng, Zhengzheng Song, Juan Chen, Zhangui Tang, Baisheng Wang · 2024 · Heliyon
  47. A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma
    van Duijn, Anneloes, Willemsen, Karin J., van Uden, Nathalie O. P., Hoyng, Lieke, Erades, Sterre, Koster, Jan, Luiten, Rosalie M., Bakker, Walbert J. · 2022 · Cancer Immunology, Immunotherapy
  48. Applications of pyroptosis activators in tumor immunotherapy
    Xin Bao, Mengmeng Sun, Lingfei Meng, Hong Zhang, Xuan Yi, Peng Zhang · 2024 · Materials Today Bio
  49. The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer
    Chen Liu, Yuhan Huang, Yaoyuan Cui, Jun Zhou, Xu Qin, Li Zhang, Xi Li, Yuan Li, Ensong Guo, Bin Yang et al. · 2022 · Frontiers in Immunology
  50. CDK4/6 Inhibitors: Mechanisms of Resistance and Potential Biomarkers of Responsiveness in Breast Cancer
    Bülent Çetin, Chiara A. Wabl, Özge Gümüşay · 2022 · Future Oncology
  51. Quantitative landscapes reveal trajectories of cell-state transitions associated with drug resistance in melanoma
    Maalavika Pillai, Zihao Chen, Mohit Kumar Jolly, Chunhe Li · 2022 · iScience
  52. CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
    Mariusz Shrestha, Dong‐Yu Wang, Yaacov Ben‐David, Eldad Zacksenhaus · 2023 · Oncogenesis
  53. circRNA-sponging: a pipeline for extensive analysis of circRNA expression and their role in miRNA sponging
    Markus Hoffmann, Leon Schwartz, Octavia-Andreea Ciora, Nico Trummer, Lina-Liv Willruth, Jakub Jankowski, Hye‐Kyung Lee, Jan Baumbach, Priscilla A. Furth, Lothar G. Hennighausen et al. · 2023 · Bioinformatics Advances
  54. Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
    Claudia Cerella, Mario A. Dicato, Marc F. Diederich · 2023 · Pharmacological Research
  55. Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses
    Xing Hu, Zhengang Hu, Hao Zhang, Nan Zhang, Hao Feng, Xiaomin Jia, Chi Zhang, Quan Cheng · 2023 · Cancer Letters
  56. Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors
    Chengliang Sun, Yuling He, Gefei Wang, Guoyu Zhang, Yu Zhang, Hao Shen, Lingrong Hu, Yanze Sun, Binjian Jiang, Xiao Wang et al. · 2024 · Journal of Medicinal Chemistry
  57. Estimating the impact of single-cell RNA sequencing of human tissues on drug target validation
    Emma Dann, Erin A. Teeple, Rasa Elmentaite, Kerstin B. Meyer, Giorgio Gaglia, Frank Oliver Nestle, Virginia Savova, Emanuele de Rinaldis, Sarah Amalia Teichmann · 2024 · medRxiv
  58. Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors
    Dae Joong Kim, Swetha Anandh, Jamie L. Null, Piotr Przanowski, Sanchita Bhatnagar, Pankaj Kumar, Sarah E. Shelton, Erin E. Grundy, Katherine Bakshian Chiappinelli, Roger Dale Kamm et al. · 2023 · Nature Communications
  59. Advancements in technology for characterizing the tumor immune microenvironment
    Honglin Yan, Xianli Ju, Aoling Huang, Jingping Yuan · 2024 · International Journal of Biological Sciences
  60. Therapy-Induced Senescence: Novel Approaches for Markers Identification
    Francesco Pacifico, Fulvio Magni, Antonio Leonardi, Elvira Crescenzi · 2024 · International Journal of Molecular Sciences
  61. Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors
    Sarah Elizabeth Fenton, Jeffrey Alan Sosman, Sunandana Chandra · 2019 · Cancer Drug Resistance
  62. Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy
    Anna Pasetto, Yong‐Chen Lu · 2021 · Frontiers in Immunology
  63. Water Droplet-in-Oil Digestion Method for Single-Cell Proteomics
    Takeshi Masuda, Yuma Inamori, Arisu Furukawa, Maki Yamahiro, Kazuki Momosaki, Chih‐Hsiang Chang, Daiki Kobayashi, Hiroto Ohguchi, Yawara Kawano, Shingo Ito et al. · 2022 · Analytical Chemistry
  64. Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments
    Zan He, Zijuan Xin, Qiong Yang, Chen Wang, Meng Li, Wei Rao, Zhimin Du, Jia Qi Adam Bai, Zixuan Guo, Xiuyan Ruan et al. · 2022 · eLife
  65. Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment
    Wenjin Yao, Beatriz German, Dounia Chraa, Antoine Braud, Cécile Hugel, Pierre Meyer, Guillaume Davidson, Patrick Laurette, Gabrielle Mengus, Eric Flatter et al. · 2022 · JCI Insight
  66. Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity
    Seemadri Subhadarshini, Sarthak Sahoo, Shibjyoti Debnath, Jason A. Somarelli, Mohit Kumar Jolly · 2023 · Journal for ImmunoTherapy of Cancer
  67. Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity
    Katherine Tooley, Livnat Jerby‐Arnon, Giulia Escobar, Sai Harsha Krovi, Davide Mangani, Gitanjali Dandekar, Hanning Cheng, Asaf Madi, Ella Goldschmidt, Conner Lambden et al. · 2024 · Cell Reports Medicine
  68. Engineering T Cells to Treat Cancer: The Convergence of Immuno-Oncology and Synthetic Biology
    Joseph H. Choe, Jasper Z. Williams, Wendell A. Lim · 2020 · Annual Review of Cancer Biology
  69. Activation of CD8(+) T cells contributes to antitumor effects of CDK4/6 inhibitors plus MEK inhibitors
    Teh, Jessica L.F., Erkes, Dan A., Cheng, Phil F., Tiago, Manoela, Wilski, Nicole A., Field, Conroy O., Chervoneva, Inna, Levesque, Mitch P., Xu, Xiaowei, Dummer, Reinhard et al. · 2020 · Cancer Immunology Research
  70. Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy
    Yuan Zhang, Cong Zhang, Jing He, Guichuan Lai, Wenlong Li, Haijiao Zeng, Xiaoni Zhong, Biao Xie · 2024 · Inflammation Research
  71. Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors
    Nick R. Love, Claire Williams, Emily E. Killingbeck, Alexander A. Merleev, Mohammad Saffari Doost, Lan Yu, John D. McPherson, Hidetoshi Mori, Alexander D. Borowsky, Emanual Michael Maverakis et al. · 2024 · Science Advances
  72. Engineering Multidimensional Evolutionary Forces to Combat Cancer
    Caroline Elizabeth McCoach, Trever Grant Bivona · 2019 · Cancer Discovery
  73. Defining the Skin Cellular Community Using Single-Cell Genomics to Advance Precision Medicine
    Anna Dubois, Nusayhah Hudaa Gopee, Bayanne Olabi, Muzlifah A. Haniffa · 2020 · Journal of Investigative Dermatology
  74. Single-Cell Sequencing and Its Applications in Liver Cancer
    Binle Tian, Qi Li · 2022 · Frontiers in Oncology
  75. An immunotherapy response prediction model derived from proliferative CD4+ T cells and antigen-presenting monocytes in ccRCC
    Kun Chan Zheng, Lianchong Gao, Jie Hao, Xin Zou, Xiaoyong Hu · 2022 · Frontiers in Immunology
  76. Spatially defined multicellular functional units in colorectal cancer revealed from single cell and spatial transcriptomics
    Inbal Avraham‐Davidi, Simon Mages, Johanna Klughammer, Noa Moriel, Shinya Imada, Matan Hofree, Evan M. Murray, Jonathan H. Chen, Karin Pelka, Arnav Mehta et al. · 2025 · eLife
  77. Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity
    Xue Zhang, Shishir Mani Pant, Cecily C. Ritch, Hsin‐Yao Tang, Hongguang Shao, Harsh Dweep, Yao-Yu Gong, Rebekah C. Brooks, Patricia A. Brafford, Adam J. Wolpaw et al. · 2024 · Nature Communications
  78. Cell-cell communication network-based interpretable machine learning predicts cancer patient response to immune checkpoint inhibitors
    Juhun Lee, Donghyo Kim, JungHo Kong, Doyeon Ha, Inhae Kim, Minhyuk Park, Kwanghwan Lee, Sin‐Hyeog Im, Sanguk Kim · 2024 · Science Advances
  79. Clinical Perspectives of Single-Cell RNA Sequencing
    Nayoung Kim, Hye Hyeon Eum, Hae‐Ock Lee · 2021 · Biomolecules
  80. Engineering Mice to Study Human Immunity
    Esen Sefik, Tianli Xiao, Michael Chiorazzi, Ian D. Odell, Fengrui Zhang, Kriti Agrawal, Goran Micevic, Richard Anthony Flavell · 2025 · Annual Review of Immunology
  81. Adapting systems biology to address the complexity of human disease in the single-cell era
    David S. Fischer, Martin Arreola Villanueva, Peter S. Winter, Alex K. Shalek · 2025 · Nature Reviews Genetics
  82. Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation
    Rosa Trotta, Silvia Rivis, Shikang Zhao, Marie‐Pauline Orban, Sarah Trusso Cafarello, Iris Charatsidou, Joanna Poźniak, Jonas Dehairs, Lotte Vanheer, Carlos Ariel Pulido-Vicuña et al. · 2025 · Cancer Discovery
  83. CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth
    Jiaxin Li, Zhaoyu Wang, Xiaogan Qin, Ming‐Chao Zhong, Zheng-Hai Tang, Jin Qian, Jiayu Dou, Tracy Hussell, Philip D. King, Jacques A. Nunès et al. · 2025 · Nature Communications
  84. From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures
    Yuen‐Yi Tseng, Jesse S. Boehm · 2019 · Current Opinion in Genetics & Development
  85. Targeting CDK4/6 in mantle cell lymphoma
    Christina Y. Lee, Xiangao Huang, Maurizio Di Liberto, Peter Martin, Selina Chen‐Kiang · 2020 · Annals of Lymphoma
  86. SIGNET: single-cell RNA-seq-based gene regulatory network prediction using multiple-layer perceptron bagging
    Qinhuan Luo, Yongzhen Yu, Xun Lan · 2021 · Briefings in Bioinformatics
  87. Single-cell RNA sequencing in melanoma: what have we learned so far?
    Su Yin Lim, Helen Rizos · 2024 · EBioMedicine
  88. Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity
    Gérémy Sannier, Mathieu Dubé, DE Kaufmann · 2020 · Frontiers in Microbiology
  89. Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes
    David Michael Woods, Andressa S. Laino, Aidan F. Winters, Jason Alexandre, Dan Freeman, Vinay P. Rao, Santi S. Adavani, Jeffrey S. Weber, Pratip K. Chattopadhyay · 2020 · JCI Insight
  90. Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism
    Baptiste Louveau, Matthieu Resche‐Rigon, Thierry Lesimple, Laetitia Da Meda, Marc Pracht, Barouyr Baroudjian, Julie Delyon, Mona Amini‐Adlé, Caroline Dutriaux, Coralie Reger de Moura et al. · 2021 · Clinical Cancer Research
  91. Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade
    Xavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea, Daniela Cerezo‐Wallis, Tonantzin G. Calvo, Cynthia Mucientes, David Olmeda, Javier Suárez, Sergio Oterino-Sogo, Lola Martínez et al. · 2025 · Nature Cancer
  92. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates
    Yuan-Chieh Yeh, Bashir Lawal, Michael Hsiao, Tse‐Hung Huang, Chi‐Ying F. Huang · 2021 · Biomedicines
  93. Multimodal predictors for precision immunotherapy
    Lisanne M. Roelofsen, Paulien Kaptein, Daniela S. Thommen · 2022 · Immuno-Oncology Technology
  94. Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancers
    Anca Apavaloaei, Leslie Hesnard, Marie‐Pierre Hardy, Basma Benabdallah, Grégory Ehx, Catherine Thériault, Jean‐Philippe Laverdure, Chantal Durette, Joël Lanoix, Mathieu Courcelles et al. · 2022 · Cell Reports
  95. Integrative insights and clinical applications of single-cell sequencing in cancer immunotherapy
    Zaoqu Liu, Huanyun Li, Qin Dang, Siyuan Weng, Mengjie Duo, Jinxiang Lv, Xinwei Han · 2022 · Cellular and Molecular Life Sciences
  96. Advancements in melanoma cancer metastasis models
    Luiza Martins Nascentes Melo, Suresh Kumar, Valeria Riess, Krystina J. Szylo, Robin Tamara Eisenburger, Dirk Schadendorf, Jessalyn M. Ubellacker, Alpaslan Tasdogan · 2022 · Pigment Cell & Melanoma Research
  97. Dynamical hallmarks of cancer: Phenotypic switching in melanoma and epithelial-mesenchymal plasticity
    Paras Jain, Maalavika Pillai, Atchuta Srinivas Duddu, Jason A. Somarelli, Yogesh Goyal, Mohit Kumar Jolly · 2023 · Seminars in Cancer Biology
  98. Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer
    Mehdi Chaib, Jeremiah Ray Holt, Emilie L. Fisher, Laura M. Sipe, Margaret Sue Bohm, Sydney C. Joseph, Boston W. Simmons, Samson Eugin Simon, Johnathan R. Yarbro, Ubaid A. Tanveer et al. · 2023 · Science Advances
  99. My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer
    Alexander Levitzki, Shoshana Klein · 2019 · Proceedings of the National Academy of Sciences
  100. Advanced Melanoma
    Alexandra M. Haugh, April K.S. Salama, Douglas Buckner Johnson · 2020 · Hematology/Oncology Clinics of North America